Ryan Cohlhepp

Companies

• Bicara Therapeutics Inc.Chief executive officer Sep 10, 2026 to now¹
• Bicara Therapeutics Inc.Board member Oct 8, 2025 to now²
• Bicara Therapeutics Inc.Chief operating officer Sep 12, 2024 to now³
• Bicara Therapeutics Inc.President Sep 12, 2024 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BTBicara Therapeutics Inc. BCAX181,641 shares⁴$3.1M at $17.14Sep 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Sold 3,442 shares at $23.43 of Bicara Therapeutics Inc.⁴
• Sep 8, 2026Sold 14,058 shares at $22.77 of Bicara Therapeutics Inc.⁴
• Sep 8, 2026Exercised options 17,500 shares at $3.79 of Bicara Therapeutics Inc.⁴
• Aug 10, 2026Sold 18,750 shares at $27.98 of Bicara Therapeutics Inc.⁵
• Aug 10, 2026Exercised options 18,750 shares at $3.79 of Bicara Therapeutics Inc.⁵
• Jul 9, 2026Sold 536 shares at $29.00 of Bicara Therapeutics Inc.⁶
• Jul 8, 2026Sold 1,075 shares at $30.35 of Bicara Therapeutics Inc.⁶
• Jul 8, 2026Sold 4,306 shares at $29.80 of Bicara Therapeutics Inc.⁶
• Jul 8, 2026Sold 22,833 shares at $28.76 of Bicara Therapeutics Inc.⁶
• Jul 8, 2026Exercised options 18,750 shares at $3.79 of Bicara Therapeutics Inc.⁶
• May 15, 2026Sold 4,500 shares at $20.29 of Bicara Therapeutics Inc.⁷
• May 15, 2026Sold 8,000 shares at $20.29 of Bicara Therapeutics Inc.⁷
• May 15, 2026Exercised options 8,000 shares at $3.79 of Bicara Therapeutics Inc.⁷
• Apr 15, 2026Sold 4,500 shares at $23.01 of Bicara Therapeutics Inc.⁸
• Apr 15, 2026Sold 8,000 shares at $23.01 of Bicara Therapeutics Inc.⁸
• Apr 15, 2026Exercised options 8,000 shares at $3.79 of Bicara Therapeutics Inc.⁸
• Mar 16, 2026Sold 4,500 shares at $19.66 of Bicara Therapeutics Inc.⁹
• Mar 16, 2026Sold 8,000 shares at $19.66 of Bicara Therapeutics Inc.⁹
• Mar 16, 2026Exercised options 8,000 shares at $3.79 of Bicara Therapeutics Inc.⁹
• Mar 3, 2026Sold 4,500 shares at $18.16 of Bicara Therapeutics Inc.¹⁰
• Mar 3, 2026Sold 12,892 shares at $18.16 of Bicara Therapeutics Inc.¹⁰
• Mar 3, 2026Exercised options 12,892 shares at $3.79 of Bicara Therapeutics Inc.¹⁰
• Feb 25, 2026Sold 523 shares at $18.04 of Bicara Therapeutics Inc.¹¹
• Feb 25, 2026Sold 3,108 shares at $18.04 of Bicara Therapeutics Inc.¹¹
• Feb 25, 2026Exercised options 3,108 shares at $3.79 of Bicara Therapeutics Inc.¹¹